Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Registry of Patients Being Treated With Norditropin, Recombinant Human Growth Hormone

Next Previous
Search
Trial Profile

Registry of Patients Being Treated With Norditropin, Recombinant Human Growth Hormone

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Mar 2023

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Somatropin (Primary)
  • Indications Dwarfism; Growth disorders; Short stature; Somatotropin deficiency
  • Focus Therapeutic Use
  • Acronyms ANSWER
  • Sponsors Novo Nordisk

    • Most Recent Events

    • 22 Mar 2023 Results of secondary analysis from NCT00960128 and NCT01009905 assessing the effectiveness and safety of Norditropin (somatropin, Novo Nordisk) with up to 10 years of follow-up in children with TS published in the Journal of Clinical Endocrinology and Metabolism
    • 23 Mar 2021 Results assessing effectiveness and Safety of Early Growth Hormone Treatment in Children Born Small for Gestational Age from NordiNet IOS (NCT00960128) and ANSWER (NCT01009905) programs presented at the 103rd Annual Meeting of the Endocrine Society
    • 20 Mar 2018 Results (n=304) assessing the long term safety and effectiveness data on adult patients with growth hormone deficiency treated with Norditropin (somatropin), presented at The 100th Annual Meeting of the Endocrine Society.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top